Lakeshore Biopharma Co Stock Performance

LSBCF Stock   0.16  0.1  38.12%   
The company secures a Beta (Market Risk) of -0.64, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning LakeShore Biopharma are expected to decrease at a much lower rate. During the bear market, LakeShore Biopharma is likely to outperform the market. At this point, LakeShore Biopharma has a negative expected return of -1.38%. Please make sure to verify LakeShore Biopharma's maximum drawdown, daily balance of power, period momentum indicator, as well as the relationship between the skewness and day typical price , to decide if LakeShore Biopharma performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days LakeShore Biopharma Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
1
Will LakeShore Biopharma Co. Ltd stock outperform foreign stocks - Portfolio Gains Summary Safe Capital Growth Trade Ideas - newser.com
11/12/2025
2
Will LakeShore Biopharma Co. Ltd stock beat value stocks - Risk Management Long-Term Safe Investment Ideas - newser.com
11/18/2025
3
Will LakeShore Biopharma Co. Ltd stock test record highs in 2025 - Day Trade AI Enhanced Execution Alerts - Newser
12/01/2025
4
Aug Ideas Is LakeShore Biopharma Co Ltd stock gaining market share - July 2025 Summary Long-Term Growth Plans - B NI V
12/08/2025
5
Will LakeShore Biopharma Co. Ltd Equity Warrant stock remain a Wall Street favorite - Candlestick Trading Patterns Free Explosive Wealth Accumulation - ulpravda...
01/07/2026
6
LakeShore Biopharma Sets February 12 EGM to Approve Going-Private Merger - TipRanks
01/20/2026
7
Buyer group questions LakeShore Biopharma take-private after RMB576.5m liability - stocktitan.net
02/06/2026
Begin Period Cash Flow246.6 M
Total Cashflows From Investing Activities-17 M

LakeShore Biopharma Relative Risk vs. Return Landscape

If you would invest  83.00  in LakeShore Biopharma Co on November 11, 2025 and sell it today you would lose (57.00) from holding LakeShore Biopharma Co or give up 68.67% of portfolio value over 90 days. LakeShore Biopharma Co is currently producing negative expected returns and takes up 8.0615% volatility of returns over 90 trading days. Put another way, 72% of traded stocks are less volatile than LakeShore, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon LakeShore Biopharma is expected to under-perform the market. In addition to that, the company is 10.07 times more volatile than its market benchmark. It trades about -0.17 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of volatility.

LakeShore Biopharma Target Price Odds to finish over Current Price

The tendency of LakeShore Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.16 90 days 0.16 
close to 99
Based on a normal probability distribution, the odds of LakeShore Biopharma to move above the current price in 90 days from now is close to 99 (This LakeShore Biopharma Co probability density function shows the probability of LakeShore Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon LakeShore Biopharma Co has a beta of -0.64. This indicates as returns on the benchmark increase, returns on holding LakeShore Biopharma are expected to decrease at a much lower rate. During a bear market, however, LakeShore Biopharma Co is likely to outperform the market. Additionally LakeShore Biopharma Co has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   LakeShore Biopharma Price Density   
       Price  

Predictive Modules for LakeShore Biopharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as LakeShore Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of LakeShore Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.278.40
Details
Intrinsic
Valuation
LowRealHigh
0.010.258.38
Details

LakeShore Biopharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. LakeShore Biopharma is not an exception. The market had few large corrections towards the LakeShore Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold LakeShore Biopharma Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of LakeShore Biopharma within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-1.04
β
Beta against Dow Jones-0.64
σ
Overall volatility
0.09
Ir
Information ratio -0.15

LakeShore Biopharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of LakeShore Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for LakeShore Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
LakeShore Biopharma generated a negative expected return over the last 90 days
LakeShore Biopharma has high historical volatility and very poor performance
LakeShore Biopharma has some characteristics of a very speculative penny stock
LakeShore Biopharma has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 614.96 M. Net Loss for the year was (99.98 M) with profit before overhead, payroll, taxes, and interest of 0.
LakeShore Biopharma generates negative cash flow from operations
LakeShore Biopharma has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Buyer group questions LakeShore Biopharma take-private after RMB576.5m liability - stocktitan.net

LakeShore Biopharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of LakeShore Stock often depends not only on the future outlook of the current and potential LakeShore Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. LakeShore Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding106.9 M
Cash And Short Term Investments28.1 M

LakeShore Biopharma Fundamentals Growth

LakeShore Stock prices reflect investors' perceptions of the future prospects and financial health of LakeShore Biopharma, and LakeShore Biopharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LakeShore Stock performance.

About LakeShore Biopharma Performance

By analyzing LakeShore Biopharma's fundamental ratios, stakeholders can gain valuable insights into LakeShore Biopharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if LakeShore Biopharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if LakeShore Biopharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 693.72  454.65 
Return On Tangible Assets(0.09)(0.08)
Return On Capital Employed(0.18)(0.19)
Return On Assets(0.07)(0.07)
Return On Equity(0.23)(0.24)

Things to note about LakeShore Biopharma performance evaluation

Checking the ongoing alerts about LakeShore Biopharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for LakeShore Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
LakeShore Biopharma generated a negative expected return over the last 90 days
LakeShore Biopharma has high historical volatility and very poor performance
LakeShore Biopharma has some characteristics of a very speculative penny stock
LakeShore Biopharma has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 614.96 M. Net Loss for the year was (99.98 M) with profit before overhead, payroll, taxes, and interest of 0.
LakeShore Biopharma generates negative cash flow from operations
LakeShore Biopharma has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Buyer group questions LakeShore Biopharma take-private after RMB576.5m liability - stocktitan.net
Evaluating LakeShore Biopharma's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate LakeShore Biopharma's stock performance include:
  • Analyzing LakeShore Biopharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LakeShore Biopharma's stock is overvalued or undervalued compared to its peers.
  • Examining LakeShore Biopharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating LakeShore Biopharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of LakeShore Biopharma's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of LakeShore Biopharma's stock. These opinions can provide insight into LakeShore Biopharma's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating LakeShore Biopharma's stock performance is not an exact science, and many factors can impact LakeShore Biopharma's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for LakeShore Stock analysis

When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios